196 related articles for article (PubMed ID: 8216019)
1. Impact of delayed treatment in growing posterior uveal melanomas.
Augsburger JJ; Vrabec TR
Arch Ophthalmol; 1993 Oct; 111(10):1382-6. PubMed ID: 8216019
[TBL] [Abstract][Full Text] [Related]
2. Uveal melanoma and pregnancy. A report of 16 cases.
Shields CL; Shields JA; Eagle RC; De Potter P; Menduke H
Ophthalmology; 1991 Nov; 98(11):1667-73. PubMed ID: 1800927
[TBL] [Abstract][Full Text] [Related]
3. Long-term survival in choroidal and ciliary body melanoma after enucleation versus plaque radiation therapy.
Augsburger JJ; Corrêa ZM; Freire J; Brady LW
Ophthalmology; 1998 Sep; 105(9):1670-8. PubMed ID: 9754176
[TBL] [Abstract][Full Text] [Related]
4. Matched group study of surgical resection versus cobalt-60 plaque radiotherapy for primary choroidal or ciliary body melanoma.
Augsburger JJ; Lauritzen K; Gamel JW; DeBrakeleer DJ; Lowry JC; Eisenman R
Ophthalmic Surg; 1990 Oct; 21(10):682-8. PubMed ID: 2250849
[TBL] [Abstract][Full Text] [Related]
5. Choroidal-ciliary body melanoma. A multivariate survival analysis of tumor location.
McLean IW; Ainbinder DJ; Gamel JW; McCurdy JB
Ophthalmology; 1995 Jul; 102(7):1060-4. PubMed ID: 9121753
[TBL] [Abstract][Full Text] [Related]
6. [Late results in treating uveal melanomas. A comparative evaluation of enucleation and organ-preserving treatment methods].
Libman ES; Brovkina AF; Bezrukov AV
Oftalmol Zh; 1989; (6):336-8. PubMed ID: 2622596
[TBL] [Abstract][Full Text] [Related]
7. Plaque radiotherapy for management of ciliary body and choroidal melanoma with extraocular extension.
Gündüz K; Shields CL; Shields JA; Cater J; Brady L
Am J Ophthalmol; 2000 Jul; 130(1):97-102. PubMed ID: 11004266
[TBL] [Abstract][Full Text] [Related]
8. Expression and prognostic value of putative cancer stem cell markers CD117 and CD15 in choroidal and ciliary body melanoma.
Lukenda A; Dotlic S; Vukojevic N; Saric B; Vranic S; Zarkovic K
J Clin Pathol; 2016 Mar; 69(3):234-9. PubMed ID: 26290260
[TBL] [Abstract][Full Text] [Related]
9. Clinical Features, Metastasis, and Survival in Patients Younger Than 21 Years With Posterior Uveal Melanoma.
Fry MV; Augsburger JJ; Corrêa ZM
JAMA Ophthalmol; 2019 Jan; 137(1):75-81. PubMed ID: 30422230
[TBL] [Abstract][Full Text] [Related]
10. Survival, anatomic, and functional long-term results in choroidal and ciliary body melanoma after ruthenium brachytherapy (15 years' experience with beta-rays).
Rouberol F; Roy P; Kodjikian L; Gérard JP; Jean-Louis B; Grange JD
Am J Ophthalmol; 2004 May; 137(5):893-900. PubMed ID: 15126155
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors for survival after enucleation for choroidal and ciliary body melanomas.
Isager P; Ehlers N; Overgaard J
Acta Ophthalmol Scand; 2004 Oct; 82(5):517-25. PubMed ID: 15453846
[TBL] [Abstract][Full Text] [Related]
12. No differences in the long-term prognosis of iris and choroidal melanomas when adjusting for tumor thickness and diameter.
Sabazade S; Herrspiegel C; Gill V; Stålhammar G
BMC Cancer; 2021 Nov; 21(1):1270. PubMed ID: 34819035
[TBL] [Abstract][Full Text] [Related]
13. The Pediatric Choroidal and Ciliary Body Melanoma Study: A Survey by the European Ophthalmic Oncology Group.
Al-Jamal RT; Cassoux N; Desjardins L; Damato B; Konstantinidis L; Coupland SE; Heimann H; Petrovic A; Zografos L; Schalenbourg A; Velazquez-Martin JP; Krema H; Bogdali A; Markiewicz A; Romanowska-Dixon B; Metz CH; Biewald E; Bornfeld N; Kiratli H; Bronkhorst IH; Jager MJ; Marinkovic M; Fili M; Seregard S; Frenkel S; Pe'er J; Salvi SM; Rennie IG; Rospond-Kubiak I; Kociecki J; Kiilgaard JF; Heegaard S; Cohen VM; Sagoo MS; Amiryan A; Saakyan S; Eide N; Krohn J; Midena E; Parrozzani R; Grange JD; Kilic E; Blasi MA; Saornil MA; Kivelä TT
Ophthalmology; 2016 Apr; 123(4):898-907. PubMed ID: 26854035
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factor study of survival after enucleation for juxtapapillary melanomas.
Weinhaus RS; Seddon JM; Albert DM; Gragoudas ES; Robinson N
Arch Ophthalmol; 1985 Nov; 103(11):1673-7. PubMed ID: 4062633
[TBL] [Abstract][Full Text] [Related]
15. Long-term Results of the UCSF-LBNL Randomized Trial: Charged Particle With Helium Ion Versus Iodine-125 Plaque Therapy for Choroidal and Ciliary Body Melanoma.
Mishra KK; Quivey JM; Daftari IK; Weinberg V; Cole TB; Patel K; Castro JR; Phillips TL; Char DH
Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):376-83. PubMed ID: 25841624
[TBL] [Abstract][Full Text] [Related]
16. Have choroidal and ciliary body melanomas changed during the period 1955-2000?
Isager P; Ehlers N; Overgaard J
Acta Ophthalmol Scand; 2004 Oct; 82(5):509-16. PubMed ID: 15453845
[TBL] [Abstract][Full Text] [Related]
17. A comparison of prognostic covariates for uveal melanoma.
Gamel JW; McCurdy JB; McLean IW
Invest Ophthalmol Vis Sci; 1992 May; 33(6):1919-22. PubMed ID: 1582798
[TBL] [Abstract][Full Text] [Related]
18. Long-term risk of local failure after proton therapy for choroidal/ciliary body melanoma.
Gragoudas ES; Lane AM; Munzenrider J; Egan KM; Li W
Trans Am Ophthalmol Soc; 2002; 100():43-8; discussion 48-9. PubMed ID: 12545676
[TBL] [Abstract][Full Text] [Related]
19. Age, survival predictors, and metastatic death in patients with choroidal melanoma: tentative evidence of a therapeutic effect on survival.
Damato BE; Heimann H; Kalirai H; Coupland SE
JAMA Ophthalmol; 2014 May; 132(5):605-13. PubMed ID: 24626610
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors in choroidal and ciliary body melanomas with extrascleral extension.
Pach JM; Robertson DM; Taney BS; Martin JA; Campbell RJ; O'Brien PC
Am J Ophthalmol; 1986 Mar; 101(3):325-31. PubMed ID: 3953727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
